Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type

Explore clinical trials studying Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type trial results

Recruiting

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

NCT06176690

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type, +17 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Anaplastic Large Cell Lymphoma, ALK-negative (1)
Anaplastic Large Cell Lymphoma, ALK-Positive (1)
CD30-Positive Diffuse Large B-Cell Lymphoma (1)
Hemic and Lymphatic Diseases (1)
Hodgkin Disease (1)
Hodgkin Lymphoma (1)
Immune System Diseases (1)
Immunoproliferative Disorders (1)

Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type

Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type trial results

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

Related conditions